Thousand Oaks, CA-headquartered Amgen, a leading biotechnology company, announced plans to establish a new technology and innovation center in Hyderabad, India.
Here’s a summary of the key points:
Location and Capacity:
– The facility, named Amgen India, will be located in HITEC City, Hyderabad.
– It will occupy six floors of the RMZ Spire Tower 110.
– The site can accommodate up to 3,000 employees.
– Operations are expected to begin in Q4 2024.
Purpose and Focus:
– Amgen India will primarily focus on developing and accelerating new technology solutions and digital capabilities.
– The center will enhance efficiencies across Amgen’s global enterprise.
– Key areas of focus include artificial intelligence (AI), data science, and life sciences.
Strategic Importance:
– This expansion aligns with Amgen’s mission to serve patients more effectively.
– It leverages the convergence of biotechnology and technology to increase speed, confidence, and efficiency in drug development.
– The move is seen as a significant step in Amgen’s 40-year journey as a biotechnology leader.
Choice of Location:
– Hyderabad was selected for its world-class talent pool in medicine, life sciences, and data sciences.
– The city’s rapidly advancing AI sector was also a factor in the decision.
Leadership:
– Som Chattopadhyay has been appointed as the national executive for India to lead Amgen’s expanded presence in the country.
Government Support:
– Chief Minister Sri Anumula Revanth Reddy welcomed Amgen, highlighting Hyderabad’s position as a hub for innovation and technology.
Amgen’s executive vice president David M. Reese said: “Establishing this new site in India marks a step forward in our journey to deliver on our mission to serve patients. At a time when a quickly aging global population needs more innovation, the convergence of biotechnology and technology is enabling Amgen to work with greater speed, confidence, and efficiency.”
